Promising figures offering confidence for pharma future 14:00 | 14/01/2021 Vietnamese pharmaceutical giants rushed to new business lines in 2020 to create new motivation for growth amid the ongoing pandemic complications, with some changes bringing about better results. Clearly in a happy mood, Vu Thi Thuan, chairwoman of the countryâs second-largest publicly-traded drugmaker Traphaco JSC, is looking towards a bright future in 2021 on the back of good performance last year. Traphaco, which boasts three big shareholders in State Capital Investment Corporation (35.67 per cent), Magbi Fund Ltd. (24.99 per cent), and Super Delta Pte., Ltd. (15.12 per cent), will organise a conference in the next few days to review 2020 operations and discuss the targets for this year.